NKX2-8 and neoplasm: Figs. 6E and S5E showed that after treatment with Pirarubicin, the tumor sizes of mice bearing either 5637/Nkx2.8-shRNA or scramble cells were much smaller when treated with Tariquidar, compared to those treated with DMSO.